Contributing to our community in 2020

Posted:
17
December 2020

Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception.

2020 has been a year like no other.

As the COVID-19 pandemic swept across the globe we witnessed an international health crisis which commanded the attention of health care professionals, Governments, businesses, and institutions.

Charities saw a fall in donations which has impacted vital research,care and education. It is more important than ever to raise money for those less fortunate and help continue vital charitable services.

Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception. We have made substantial charitable contributions to a number of charities this year including: Global’s Make Some Noise, Diabetes UK, Robes, the British Heart Foundation and Practical Action. The causes are varied but close to the hearts of our staff and sponsors.

A message from Robes

"Thank you to all who donated to the Robes project via Richmond Pharmacology this year, very much indeed for your generosity. You collectively raised the amazing sum of £5,500 which is absolutely wonderful and will be a huge help for Robes this year."

Canon Giles Goddard, St John’s Church, Waterloo

Latest news

Upcoming Event

The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

4 – 5 December 2020
The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.
View event

Contributing to our community in 2020

December 17, 2020
Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception.
Read more

Richmond Pharmacology supports Cardior Pharmaceuticals with the pioneering trial of an oligonucleotide-based drug in heart failure patients

December 14, 2020
Richmond Pharmacology is delighted to welcome the positive Phase Ib results of Cardior Pharmaceuticals lead compound CDR132L for heart failure.
Read more

Marking a milestone for gene editing

November 10, 2020
We are pleased to share that Richmond Pharmacology, in partnership with Intellia Therapeutics and the Royal Free Hospital, have treated the first patient in a landmark CRISPR/Cas9 clinical trial of NTLA-2001
Read more